nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—NISCH—uterine cervix—cervical cancer	0.0242	0.0472	CbGeAlD
Oxymetazoline—NISCH—decidua—cervical cancer	0.0231	0.045	CbGeAlD
Oxymetazoline—HTR1E—female gonad—cervical cancer	0.0225	0.0438	CbGeAlD
Oxymetazoline—NISCH—mammalian vulva—cervical cancer	0.0212	0.0413	CbGeAlD
Oxymetazoline—ADRA1D—epithelium—cervical cancer	0.0204	0.0397	CbGeAlD
Oxymetazoline—NISCH—uterus—cervical cancer	0.0202	0.0393	CbGeAlD
Oxymetazoline—ADRA1B—renal system—cervical cancer	0.0193	0.0377	CbGeAlD
Oxymetazoline—NISCH—female gonad—cervical cancer	0.0165	0.0322	CbGeAlD
Oxymetazoline—NISCH—vagina—cervical cancer	0.0164	0.032	CbGeAlD
Oxymetazoline—ADRA1D—female reproductive system—cervical cancer	0.0151	0.0295	CbGeAlD
Oxymetazoline—HTR2B—uterine cervix—cervical cancer	0.014	0.0274	CbGeAlD
Oxymetazoline—HTR2B—decidua—cervical cancer	0.0134	0.0261	CbGeAlD
Oxymetazoline—HTR2B—endometrium—cervical cancer	0.0127	0.0248	CbGeAlD
Oxymetazoline—HTR2B—uterus—cervical cancer	0.0117	0.0228	CbGeAlD
Oxymetazoline—ADRA1A—epithelium—cervical cancer	0.0117	0.0228	CbGeAlD
Oxymetazoline—HTR1B—female reproductive system—cervical cancer	0.0117	0.0228	CbGeAlD
Oxymetazoline—HTR1D—female reproductive system—cervical cancer	0.0113	0.0221	CbGeAlD
Oxymetazoline—HTR2C—female reproductive system—cervical cancer	0.0112	0.0218	CbGeAlD
Oxymetazoline—ADRA2C—uterine cervix—cervical cancer	0.0111	0.0216	CbGeAlD
Oxymetazoline—ADRA1A—renal system—cervical cancer	0.0109	0.0212	CbGeAlD
Oxymetazoline—NISCH—lymph node—cervical cancer	0.0106	0.0207	CbGeAlD
Oxymetazoline—ADRA2C—decidua—cervical cancer	0.0105	0.0205	CbGeAlD
Oxymetazoline—HTR2B—female reproductive system—cervical cancer	0.0105	0.0205	CbGeAlD
Oxymetazoline—ADRA2C—renal system—cervical cancer	0.0103	0.0202	CbGeAlD
Oxymetazoline—ADRA2C—endometrium—cervical cancer	0.01	0.0195	CbGeAlD
Oxymetazoline—ADRA2C—mammalian vulva—cervical cancer	0.00967	0.0189	CbGeAlD
Oxymetazoline—HTR2B—vagina—cervical cancer	0.00952	0.0186	CbGeAlD
Oxymetazoline—ADRA2C—uterus—cervical cancer	0.00921	0.018	CbGeAlD
Oxymetazoline—ADRA2A—uterine cervix—cervical cancer	0.00882	0.0172	CbGeAlD
Oxymetazoline—ADRA2A—decidua—cervical cancer	0.00841	0.0164	CbGeAlD
Oxymetazoline—ADRA2A—endometrium—cervical cancer	0.00798	0.0156	CbGeAlD
Oxymetazoline—ADRA2A—mammalian vulva—cervical cancer	0.00772	0.015	CbGeAlD
Oxymetazoline—HTR2A—epithelium—cervical cancer	0.00757	0.0147	CbGeAlD
Oxymetazoline—ADRA2C—female gonad—cervical cancer	0.00754	0.0147	CbGeAlD
Oxymetazoline—ADRA2C—vagina—cervical cancer	0.00749	0.0146	CbGeAlD
Oxymetazoline—ADRA2A—uterus—cervical cancer	0.00735	0.0143	CbGeAlD
Oxymetazoline—HTR2A—renal system—cervical cancer	0.00702	0.0137	CbGeAlD
Oxymetazoline—ADRA2A—female reproductive system—cervical cancer	0.00661	0.0129	CbGeAlD
Oxymetazoline—HTR2B—lymph node—cervical cancer	0.00616	0.012	CbGeAlD
Oxymetazoline—ADRA2A—female gonad—cervical cancer	0.00601	0.0117	CbGeAlD
Oxymetazoline—ADRA2A—vagina—cervical cancer	0.00598	0.0117	CbGeAlD
Oxymetazoline—HTR2A—female reproductive system—cervical cancer	0.00562	0.011	CbGeAlD
Oxymetazoline—HTR2A—vagina—cervical cancer	0.00508	0.00991	CbGeAlD
Oxymetazoline—ADRA2C—lymph node—cervical cancer	0.00485	0.00945	CbGeAlD
Oxymetazoline—ADRA2A—lymph node—cervical cancer	0.00387	0.00754	CbGeAlD
Oxymetazoline—HTR1D—Signaling by GPCR—AKAP13—cervical cancer	0.000851	0.00175	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—WNT2—cervical cancer	0.000845	0.00174	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	0.00084	0.00172	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—AKAP13—cervical cancer	0.000834	0.00171	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—WNT2—cervical cancer	0.00083	0.0017	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AKAP13—cervical cancer	0.000802	0.00165	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	0.000802	0.00165	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.000801	0.00164	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—TAAR6—cervical cancer	0.000784	0.00161	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AKAP13—cervical cancer	0.000783	0.00161	CbGpPWpGaD
Oxymetazoline—ADRA1A—AMPK Signaling—TP53—cervical cancer	0.000764	0.00157	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—WNT2—cervical cancer	0.000749	0.00154	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKAP13—cervical cancer	0.000742	0.00152	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—WNT5A—cervical cancer	0.000735	0.00151	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TAAR6—cervical cancer	0.000734	0.00151	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKAP13—cervical cancer	0.000729	0.0015	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	0.000728	0.0015	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKAP13—cervical cancer	0.000725	0.00149	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—WNT5A—cervical cancer	0.00072	0.00148	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—WNT2—cervical cancer	0.00072	0.00148	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TAAR6—cervical cancer	0.000719	0.00148	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—WNT2—cervical cancer	0.0007	0.00144	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKAP13—cervical cancer	0.000696	0.00143	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—WNT2—cervical cancer	0.000689	0.00141	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKAP13—cervical cancer	0.000677	0.00139	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—WNT5A—cervical cancer	0.000676	0.00139	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TAAR6—cervical cancer	0.000675	0.00139	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKAP13—cervical cancer	0.000666	0.00137	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKAP13—cervical cancer	0.000658	0.00135	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—WNT5A—cervical cancer	0.00064	0.00132	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000633	0.0013	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKAP13—cervical cancer	0.000632	0.0013	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—WNT5A—cervical cancer	0.000629	0.00129	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TAAR6—cervical cancer	0.000628	0.00129	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.000625	0.00128	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKAP13—cervical cancer	0.000615	0.00126	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—WNT2—cervical cancer	0.000612	0.00126	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000611	0.00125	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKAP13—cervical cancer	0.000605	0.00124	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000604	0.00124	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000592	0.00121	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—WNT2—cervical cancer	0.000573	0.00118	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.000569	0.00117	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	0.000568	0.00117	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	0.000567	0.00116	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—WNT2—cervical cancer	0.000561	0.00115	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00055	0.00113	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.000549	0.00113	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.000545	0.00112	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.000545	0.00112	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	0.000537	0.0011	CbGpPWpGaD
Oxymetazoline—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000534	0.0011	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—WNT5A—cervical cancer	0.000531	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TAAR6—cervical cancer	0.00053	0.00109	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.000527	0.00108	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—WNT5A—cervical cancer	0.000522	0.00107	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TAAR6—cervical cancer	0.000521	0.00107	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKAP13—cervical cancer	0.000503	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000499	0.00102	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000497	0.00102	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKAP13—cervical cancer	0.000493	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—WNT2—cervical cancer	0.00049	0.00101	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000474	0.000973	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000473	0.000971	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—CA9—cervical cancer	0.000467	0.000959	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000464	0.000952	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000463	0.000951	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.000463	0.00095	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—NOTCH2—cervical cancer	0.00045	0.000923	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.000443	0.000909	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000434	0.000892	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000431	0.000885	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000431	0.000885	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.00043	0.000884	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.00043	0.000883	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000425	0.000873	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—WNT5A—cervical cancer	0.000425	0.000873	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000414	0.000849	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000413	0.000847	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000407	0.000836	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.000399	0.00082	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000389	0.000798	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—CA9—cervical cancer	0.000379	0.000779	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000374	0.000768	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000373	0.000766	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000372	0.000763	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000369	0.000758	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—HES1—cervical cancer	0.000369	0.000757	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000366	0.000752	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000363	0.000745	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000361	0.000742	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000357	0.000734	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000336	0.00069	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000335	0.000689	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000324	0.000666	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TERT—cervical cancer	0.000323	0.000663	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000322	0.000662	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000317	0.000652	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000313	0.000643	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000308	0.000633	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000305	0.000626	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000298	0.000613	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—FGFR3—cervical cancer	0.000296	0.000609	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000295	0.000605	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.00028	0.000576	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.00028	0.000575	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—NOTCH1—cervical cancer	0.000278	0.000571	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000274	0.000563	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000261	0.000536	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000255	0.000523	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HES1—cervical cancer	0.00025	0.000513	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—EGFR—cervical cancer	0.000248	0.000509	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HES1—cervical cancer	0.000245	0.000502	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000235	0.000484	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HES1—cervical cancer	0.00023	0.000472	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000226	0.000464	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.00022	0.000452	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000219	0.00045	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.000444	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TERT—cervical cancer	0.000214	0.00044	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000214	0.000439	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—MTOR—cervical cancer	0.000209	0.000428	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000201	0.000414	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000201	0.000413	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000197	0.000404	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000196	0.000403	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000193	0.000396	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000192	0.000395	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CASP3—cervical cancer	0.000192	0.000394	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—TP53—cervical cancer	0.00019	0.00039	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—MTHFR—cervical cancer	0.00019	0.000389	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000189	0.000387	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000187	0.000385	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000185	0.000381	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CTNNB1—cervical cancer	0.000185	0.00038	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000185	0.000379	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.000185	0.000379	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.00018	0.00037	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000179	0.000367	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000177	0.000364	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—TP53—cervical cancer	0.000177	0.000364	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000174	0.000356	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000172	0.000353	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000169	0.000347	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000168	0.000345	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—EGFR—cervical cancer	0.000165	0.000338	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000162	0.000334	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000161	0.000331	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—STAT3—cervical cancer	0.000161	0.000331	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000161	0.000331	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000158	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000158	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000156	0.000319	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000155	0.000319	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000155	0.000317	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000154	0.000316	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000149	0.000306	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000146	0.000301	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EGFR—cervical cancer	0.000146	0.000301	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000146	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000145	0.000298	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—TP53—cervical cancer	0.000144	0.000296	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000144	0.000295	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000143	0.000293	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.000141	0.00029	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000141	0.00029	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.00014	0.000287	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MTOR—cervical cancer	0.000138	0.000284	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000138	0.000284	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000136	0.00028	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000275	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.00013	0.000267	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.00013	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.00013	0.000267	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000129	0.000266	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000128	0.000264	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CASP3—cervical cancer	0.000127	0.000261	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.00026	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	0.000125	0.000257	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000125	0.000256	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TP53—cervical cancer	0.000123	0.000252	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	0.000123	0.000252	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000122	0.00025	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000121	0.000249	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MTOR—cervical cancer	0.000121	0.000248	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000246	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000245	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.000119	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000118	0.000242	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	0.000115	0.000237	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CASP3—cervical cancer	0.000111	0.000228	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000111	0.000227	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—STAT3—cervical cancer	0.000109	0.000224	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000109	0.000224	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000108	0.000222	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	0.000107	0.00022	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—STAT3—cervical cancer	0.000107	0.00022	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	0.000106	0.000218	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000105	0.000215	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MTOR—cervical cancer	0.000102	0.000209	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—STAT3—cervical cancer	0.0001	0.000206	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CASP3—cervical cancer	0.0001	0.000206	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000206	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—cervical cancer	9.93e-05	0.000204	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	9.85e-05	0.000202	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—cervical cancer	9.72e-05	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	9.68e-05	0.000199	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CASP3—cervical cancer	9.65e-05	0.000198	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CASP3—cervical cancer	9.38e-05	0.000193	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—cervical cancer	9.35e-05	0.000192	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	9.3e-05	0.000191	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CASP3—cervical cancer	9.23e-05	0.00019	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—cervical cancer	9.13e-05	0.000188	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MTOR—cervical cancer	9.11e-05	0.000187	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	9.04e-05	0.000186	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MTOR—cervical cancer	8.92e-05	0.000183	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	8.9e-05	0.000183	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—cervical cancer	8.5e-05	0.000174	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—cervical cancer	8.44e-05	0.000173	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CASP3—cervical cancer	8.38e-05	0.000172	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—cervical cancer	8.34e-05	0.000171	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MTOR—cervical cancer	8.29e-05	0.00017	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CASP3—cervical cancer	8.2e-05	0.000168	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—cervical cancer	8.16e-05	0.000168	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—cervical cancer	8.11e-05	0.000166	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	8.08e-05	0.000166	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	7.91e-05	0.000162	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—cervical cancer	7.88e-05	0.000162	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—cervical cancer	7.76e-05	0.000159	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—cervical cancer	7.67e-05	0.000158	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—cervical cancer	7.67e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CASP3—cervical cancer	7.62e-05	0.000156	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—cervical cancer	7.37e-05	0.000151	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	7.35e-05	0.000151	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—cervical cancer	7.17e-05	0.000147	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—cervical cancer	7.13e-05	0.000146	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—cervical cancer	7.05e-05	0.000145	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—cervical cancer	7.04e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—cervical cancer	6.89e-05	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—cervical cancer	6.44e-05	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—cervical cancer	6.4e-05	0.000131	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—cervical cancer	6.4e-05	0.000131	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—cervical cancer	6.26e-05	0.000129	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—cervical cancer	6.19e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—cervical cancer	6.02e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—cervical cancer	5.92e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—cervical cancer	5.82e-05	0.00012	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—cervical cancer	5.37e-05	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—cervical cancer	5.26e-05	0.000108	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—cervical cancer	4.89e-05	0.0001	CbGpPWpGaD
